BiOCl is known as a highly efficient photocatalyst for degradation of pollutants. However, effective methods for fabricating BiOCl nanomaterials with well-defined facets are still lacking. In this work, a facile synthetic method was developed for the fabrication of BiOCl nanodisks with exposed {001} facets. The central feature of this approach was the use of water as the hydrolysis agent and ethylene glycol as the crystal growth inhibitor agent to tune the growth of BiOCl nanomaterial. With this approach, the size and shape of BiOCl nanostructures could be effectively tuned through adjusting the volume ratio of ethylene glycol/H2O. In addition, the mechanism of the crystal growth in this fabrication process was elucidated. The as-prepared BiOCl nanodisks with exposed {001} facets exhibited an excellent photocatalytic activity towards Rhodamine B degradation under both ultraviolet and visible light irradiations. These findings shed light on the deep understanding of formation mechanisms of BiOCl nanodisks and provide an efficient and facile method for the synthesis of high active photocatalyst.
A new quinary oxysulfide LaPbBiS3O was designed and successfully synthesized via a solid-state reaction in a sealed evacuated quartz tube. This material, composed of stacked NaCl-like [M4S6] (where M = Pb, Bi) layers and fluorite-type [La2O2] layers, crystallizes in the tetragonal space group P4/nmm with a = 4.0982(1) Å, c = 19.7754(6) Å, and Z = 2. Electrical resistivity and Hall effect measurements demonstrate that it is a narrow gap semiconductor with an activation energy of ∼17 meV. The thermopower and the figure of merit at room temperature were measured to be -52 μV/K and 0.23, respectively, which makes LaPbBiS3O and its derivatives be promising for thermoelectric applications.
It remains not fully elucidated the potential functions of Th17 cells and follicular helper T (Tfh) cells and secreting cytokines in the pathogenesis of rheumatoid arthritis (RA) and their association with disease activity. In this study, the frequencies of Th17 and Tfh cells were determined by flow cytometry, and the levels of interleukin (IL)-17, IL-21, and IL-22 were measured by ELISA in RA patients with different disease activities. The dynamic changes of cell subsets were also detected in response to disease-modify antirheumatic drugs (DMARDs) therapy. The percentages of CD3(+) CD4(+) IL-17A(+) (Th17) cells and CD3(+) CD4(+) CXCR5(+) ICOS(high) (Tfh) cells, as well as the concentrations of IL-17, IL-21, and IL-22 were significantly elevated in RA patients than those in healthy individuals. Furthermore, Tfh cells, IL-21, and IL-22 in the serum was positively correlated with the values of disease activity score. Concentrations of IL-21 and IL-22 in the serum were remarkably reduced following the DMARDs therapies. Our data suggested that Th17 cells, Tfh cells as well as the secreting cytokines may be involved in the pathogenesis of RA. The frequency of circulating Tfh cells and the productions of IL-21 and IL-22 were associated with the disease activity of RA patients, and might be potential therapeutic targets for treatment of RA.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.